scholarly journals Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry

HPB ◽  
2018 ◽  
Vol 20 (8) ◽  
pp. 768-775 ◽  
Author(s):  
Hans-Christian Pommergaard ◽  
Andreas A. Rostved ◽  
René Adam ◽  
Lau C. Thygesen ◽  
Mauro Salizzoni ◽  
...  
2018 ◽  
Vol 31 (5) ◽  
pp. 531-539 ◽  
Author(s):  
Hans-Christian Pommergaard ◽  
Andreas Arendtsen Rostved ◽  
René Adam ◽  
Lau Caspar Thygesen ◽  
Mauro Salizzoni ◽  
...  

Liver Cancer ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. 455-467
Author(s):  
Hans-Christian Pommergaard ◽  
Andreas Arendtsen Rostved ◽  
René Adam ◽  
Mauro Salizzoni ◽  
Miguel Angel Gómez Bravo ◽  
...  

Background and Aims: Prognosis after liver transplantation differs between hepatocellular carcinoma (HCC) arising in cirrhotic and non-cirrhotic livers and aetiology is poorly understood. The aim was to investigate differences in mortality after liver transplantation between these patients. Methods: We included patients from the European Liver Transplant Registry transplanted due to HCC from 1990 to November 2016 and compared cirrhotic and non-cirrhotic patients using propensity score (PS) calibration of Cox regression estimates to adjust for unmeasured confounding. Results: We included 22,787 patients, of whom 96.5% had cirrhosis. In the unadjusted analysis, non-cirrhotic patients had an increased risk of overall mortality with a hazard ratio (HR) of 1.37 (95% confidence interval [CI] 1.23–1.52). However, the HR approached unity with increasing adjustment and was 1.11 (95% CI 0.99–1.25) when adjusted for unmeasured confounding. Unadjusted, non-cirrhotic patients had an increased risk of HCC-specific mortality (HR 2.62, 95% CI 2.21–3.12). After adjustment for unmeasured confounding, the risk remained significantly increased (HR 1.62, 95% CI 1.31–2.00). Conclusions: Using PS calibration, we showed that HCC in non-cirrhotic liver has similar overall mortality, but higher HCC-specific mortality. This may be a result of a more aggressive cancer form in the non-cirrhotic liver as higher mortality could not be explained by tumour characteristics or other prognostic variables.


The Lancet ◽  
2000 ◽  
Vol 356 (9230) ◽  
pp. 621-627 ◽  
Author(s):  
René Adam ◽  
Valérie Cailliez ◽  
Pietro Majno ◽  
Vincent Karam ◽  
Paul McMaster ◽  
...  

2020 ◽  
Vol 104 (S3) ◽  
pp. S527-S528
Author(s):  
Chutwichai Tovikkai ◽  
Bunthoon Nonthasoot ◽  
Ake Pugkhem ◽  
Sunhawit Junrungsee ◽  
Goragoch Gesprasert ◽  
...  

2003 ◽  
Vol 9 (12) ◽  
pp. 1231-1243 ◽  
Author(s):  
Ren[eacute] Adam ◽  
Paul McMaster ◽  
John G. O[apos ]Grady ◽  
Denis Castaing ◽  
Jurgen L. Klempnauer ◽  
...  

2020 ◽  
Vol 26 (7) ◽  
pp. 866-877 ◽  
Author(s):  
Melina Heinemann ◽  
Rene Adam ◽  
Marina Berenguer ◽  
Darius Mirza ◽  
Seyed Ali Malek‐Hosseini ◽  
...  

2019 ◽  
Vol 71 (2) ◽  
pp. 313-322 ◽  
Author(s):  
Debashis Haldar ◽  
Barbara Kern ◽  
James Hodson ◽  
Matthew James Armstrong ◽  
Rene Adam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document